Surgery Partners Raises HealthSpan Takeover to $25.00/Share Plus Ticking Fee After $28 Bid
SGRY has more than doubled off its 52-week low of $11.41.
Summary
Surgery Partners and HealthSpan amended their merger to $25.00 per share in cash from $23.50, adding a 10% annual ticking fee worth up to $1.61 per share if the deal closes after March 1, 2027. The board rejected a $28.00 unsolicited bid as not superior on timing and regulatory risk.
Key Events · M&A and Partnerships · SGRY
-
Price Raised to $25.00 Per Share
Amendment No. 1 to the October 23, 2026 merger agreement lifts the all-cash consideration to $25.00 per share from $23.50, a 7.0% increase, for enterprise value of up to approximately $6.0 billion.
-
Ticking Fee Added for Delay
If stockholders approve but the deal has not closed by March 1, 2027, holders other than Bain Capital receive monthly cash at 10% per annum on the $25.00, or $0.208333 per share per month, capped at $1.61 per share at the October 23, 2027 outside date for a maximum $26.61.
-
Board Rejects $28.00 Unsolicited Bid
A third party proposed $28.00 per share in cash on November 3, updated November 8; the Special Committee unanimously found it not a Superior Proposal, citing materially longer time to close, greater regulatory risk and missing contractual protections.
-
Break Fee and Expense Reimbursement Raised
The Company Termination Fee rises to approximately $149.1 million, and the Company must reimburse up to $8.25 million of Buyer Parties' expenses if it terminates for a Superior Proposal before stockholder approval.
Analysis · SGRY · Industrial Applications And Services
HealthSpan (Bon Secours Mercy Health) raised its all-cash price to $25.00 per share from $23.50 after an unsolicited third party put $28.00 per share on the table on November 3, updated November 8. The board rejected the higher bid because it would take materially longer to close, carried more regulatory risk and lacked the protections the Special Committee wanted — so stockholders get a smaller headline number with a faster, more certain path to cash. To compensate for delay, holders other than Bain get a 10% annual ticking fee on the $25.00 if the deal has not closed by March 1, 2027, worth up to $1.61 per share at the October 23, 2027 outside date, for a maximum of $26.61. The price is a 7.0% increase over the original $23.50 and sits below today's $25.80 quote, meaning the market is already pricing some chance of a higher bid or a delay. The break fee rose to about $149.1 million and expense reimbursement of up to $8.25 million now applies, both of which raise the cost of a rival bidder emerging. Parent also dropped the materiality limitation on its antitrust remedy obligations, which is the concession that supports the 'regulatory certainty' claim.
How filings like this one have moved
In the 30 days to Nov 9, 2026, 51.3% of the 191 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.73%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, SGRY was trading at $25.80 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $3B. The 52-week trading range was $11.41 to $23.37. This filing was assessed with positive market sentiment and an importance score of 9 out of 10.